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Abstract: Susceptibility and/or resistance to aflatoxin B1 (AFB1) is a threshold trait governed
principally by glutathione S transferase (GST)-mediated detoxification. In poultry, domesticated
turkeys are highly sensitive to AFB1, most likely due to dysfunction in hepatic GSTs. In contrast, wild
turkeys are comparatively resistant to aflatoxicosis due to the presence of functional hepatic GSTAs
and other possible physiological and immunological interactions. The underlying genetic basis for
the disparate GST function in turkeys is unknown as are the broader molecular interactions that
control the systemic response. This study quantifies the effects of dietary AFB1 on gene expression
in the turkey spleen, specifically contrasting genetically distinct domesticated (DT, susceptible) and
Eastern wild (EW, resistant) birds. Male turkey poults were subjected to a short-term AFB1 treatment
protocol with feed supplemented with 320 ppb AFB1 beginning on day 15 of age and continuing for
14 days. Spleen tissues were harvested and subjected to deep RNA sequencing and transcriptome
analysis. Analysis of differential gene expression found the effects of AFB1 treatment on the spleen
transcriptomes considerably more prominent in the DT birds compared to EW. However, expression
of the differentially expressed genes (DEGs) was directionally biased, with the majority showing
higher expression in EW (i.e., down-regulation in DT). Significantly altered pathways included
FXR/RXR and LXR/RXR activation, coagulation system, prothrombin activation, acute phase response,
and atherosclerosis signaling. Differential extra-hepatic expression of acute phase protein genes
was confirmed by quantitative real time PCR (qRT-PCR) in the original experiment and additional
turkey lines. Results demonstrate that wild turkeys possess a capacity to more effectively respond to
AFB1 exposure.
Keywords: Poultry; turkey; transcriptome; aflatoxin B1; spleen; RNAseq
Key Contribution: Significant differences were observed and quantified in the response of the spleen
transcriptomes of domestic and wild turkeys to AFB1-treatment.
1. Introduction
Aflatoxins are mycotoxins produced by a group of heterologous fungal strains of Aspergillus.
Of these mycotoxins, aflatoxin B1 (AFB1) is the most hepatotoxic, mutagenic, and prevalent worldwide.
It is ubiquitous in foods and feeds, and poses a significant health risk to people and animals. Rapidly
absorbed in the small intestine, AFB1 is metabolized primarily in the liver where it is bioactivated
by hepatic cytochrome P450 (CYP) enzymes into the reactive and electrophilic exo-AFB1-8,9-epoxide
(AFBO). This reactive epoxide can initiate toxicity by binding to DNA, RNA, proteins, and other
critical cellular macromolecules. The principal route of AFB1 detoxification is through glutathione
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S-transferase (GST) enzymes that conjugate AFBO with glutathione (GSH). The principal determinant
of species sensitivity to AFB1 is the rate and efficiency of GST activity [1].
Poultry are among the most vulnerable animals to AFB1 displaying a wide array of adverse
effects including reduced feed intake, weight gain, and increased mortality, hepatotoxicity, and GI
hemorrhaging [1–5]. Due to likely dysfunction in hepatic GSTs rendering them unable to detoxify
AFB1, domesticated turkeys (DT) are highly sensitive to AFB1 [6–10]. Studies in turkey [11,12]
show significant association between AFB1 exposure and expression of hepatic phase I and phase
II metabolism genes and other genes important in cellular regulation, modulation of apoptosis, and
inflammatory responses.
In addition to its hepatotoxic and mutagenic effects, AFB1 is a potent immunotoxin acting
to suppress cell-mediated, humoral and phagocytic functions [13–15]. In susceptible species, the
mechanisms of AFB1 immunotoxic effects vary depending on the level and duration of exposure. Acute
exposure tends to result in immunosuppressive effects, whereas chronic exposure typically produces an
inflammatory response and apoptosis [16,17]. Immunosuppressive effects may result from inhibition
of antibody production and lymphocyte proliferation by blocked protein synthesis [18] or apoptosis in
splenocytes resulting from oxidative stress and DNA damage [17,19]. Key inflammatory responses
include monocyte infiltration in the liver [3,20] and expression of pro-inflammatory cytokines [21,22].
In domesticated turkeys, short-term AFB1 exposure suppressed transcripts of innate immune genes
in the spleen, especially antimicrobial genes. Conversely, transcripts from the protein ubiquitination
pathway and multiple interleukin-2 response genes were increased suggesting increased cytotoxic
potential or activation-induced cell death during aflatoxicosis [23]. As a consequence of AFB1-caused
immunosuppression, exposed poultry have lower resistance to secondary infections and diseases [5,24].
By contrast to modern domesticated turkeys, wild turkeys are relatively resistant to
aflatoxicosis [25], most likely due, in large part, to the expression and presence of functional hepatic
GSTAs [10]. As part of this genetic effect, we found constitutive expression of hepatic GSTA3 is
significantly higher in wild compared to domesticated turkeys [12]. Expression was also significantly
higher in AFB1-treated birds compared to controls. In the intestine, AFB1 significantly up-regulated
expression of the primary AFB1-activating P450 (CYP1A5) and produced transcriptional changes
in several tight junction proteins [26]. Significant down-regulation was seen in domesticated birds
for numerous pro-inflammatory cytokines, TGF-β and EGF and gene pathway analysis suggested
AFB1 suppression of enteroendocrine cells. We hypothesized that as in the liver and intestine, the
transcriptome of the spleen would be significantly affected by AFB1 and response in turkey would
vary by genetic type (wild vs. domestic). This study was designed to quantify the effects of dietary
AFB1 on gene expression in the turkey spleen, specifically contrasting genetically distinct domesticated
(DT, susceptible) and Eastern wild (EW, resistant) birds.
2. Results
Sequencing of RNA libraries produced an average of 12.7 M reads per library (range 8.4 M to
15.7 M per individual, Table S1). After trimming and filtering, median Q scores among the forward
and reverse reads were consistently high and ranged from 36.4 to 37.2. Average reads per treatment
group ranged from 9.6 M to 13.8 M. Of the quality-trimmed reads, ~90% mapped to the annotated
turkey gene set (NCBI Annotation 101, Table S1). Based on map position, the estimated mean insert of
the libraries was 187.2 bp.
2.1. Splenic Gene Expression
Evidence of expression (mapped reads >1.0) was detected for 19,564 genes (mean read depth =
375.4, Table S2). The number of expressed genes per individual averaged 17,406 (Table S1) representing
82.8% of the turkey gene set (tRNAs excluded). When limited to genes with mapped reads ≥3.0
(normalized), the number of expressed genes ranged from 15,886 to 16,733 among individuals with an
average of 16,335.8 detected per library (77.8% of the gene set, Table S1). Using the same cutoff value
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(normalized mapped reads ≥3.0 in at least one individual), the number of combined expressed genes
per treatment group ranged from 17,612 to 17,995 (average 17,840). Distribution of these expressed
genes by treatment group (unique and shared) are illustrated in Figure S1. A total of 16,976 genes
(90.7%) was co-expressed among all groups with similar distribution of co-expressed and uniquely
expressed gene counts.
Overall variation among the treatment groups is visualized in the principal component analysis
(PCA) of normalized read counts (Figure S2). Greatest separation between the DT groups was observed
along PC axis 1 whereas EW samples were distinguished on axis 2. One individual from the EW
control group (EW10) was uniquely distributed within the variant space. Examination of the mapped
reads for this sample found four genes with skewed expression including CD74 (CD74 molecule, major
histocompatibility complex, class II invariant chain), EEF1A1 (eukaryotic translation elongation factor
1 alpha 1), IGLL1 (immunoglobulin lambda-like polypeptide 1), and MARCO (macrophage receptor
with collagenous structure). Each of these are among the most highly observed loci (Table S2). With
the exception of IGLL1, expression of these genes was significantly lower in EW10 (1.37× to 3.0×)
compared to the other group samples. Expression of IGLL1 was 4.3× to 9.8× higher in EW10.
2.2. Differential Gene Expression
2.2.1. AFB1 Treatment Effects
The effects of AFB1 treatment on the spleen transcriptomes were considerably more prominent in
the DT birds than EW. A total of 4 differentially expressed genes (DEGs) was observed in AFB1-treated
EW compared to control birds (Table 1 and Table S3, Figure 1). Three DEGs (KCTD16, potassium channel
tetramerization domain containing 16 [LOC100550279]), fatty acid-binding protein, adipocyte-like
(FABP4); and IL13RA2, interleukin 13 receptor, alpha 2) had elevated expression in the AFB1-fed group.
The fourth, LOC104910166 a non-coding RNA (ncRNA) was down-regulated with AFB1 treatment.
This uncharacterized locus has been withdrawn by NCBI because the model on which it was based
was not predicted in the most recent turkey genome annotation (v102). Greatest fold change (FC)
was seen for (KCTD16, log2FC = 5.89). The protein encoded by this gene is an auxiliary subunit that
modulates receptor response of the inhibitory GABA-B receptors. Both IL13RA2, and FABP4 are
implicated in inflammatory response. IL12RA2 is related to IL13RA1, a subunit of the interleukin 13
receptor complex that binds IL13 with high affinity [27]. In mammals, FABP4 is expressed in adipocytes
and macrophages and has been shown to be associated with insulin resistance, atherosclerosis and
metaflammation [28].





















CNTL) 18,417 17,536 422/459 4 4 4 3/1
DT (AFB vs.
CNTL) 18,155 17,254 543/358 2353 242 35 10/25
Genetic Line
CNTL (EW vs.
DT) 18,307 17,300 695/312 344 223 106 95/11
AFB (EW vs.
DT) 18,372 17,383 575/414 435 351 216 199/17
For each comparison, the treatment groups, total number of expressed, shared and unique genes, are given. For
genes with significant false discovery rate (FDR) p values, the number of differentially expressed genes (DEGs) with
either |log2(fold change (FC))| > 1.0 and > 2.0 are shown. The number of up and down regulated genes are given for
DEGs with |log2FC| > 2.0. Genes were considered expressed in a treatment group if the by-total normalized read
count was ≥ 3.0 in any individual within the group.
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regulation especially of pro-inflammatory cytokines is a key innate immune response [29]. Pathway 
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Figure 1. Distribution of DEGs in the turkey spleens. For each genetic type, the number of DEGs
(FDR p < 0.05 and |log2FC| > 2.0) shared or unique to each treatment (AFB1 or control) are indicated in
the Venn diagram and direction of expression change (↑ or ↓) is given for each group. Circle size is
proportional to the number of DEGs.
In contrast to the EW comparison, 2353 loci were significant differentially expressed (DE) in the
AFB1-treated DT birds compared t control-fed birds (Table 1). Of these, 242 had |log2FC| > 1.0 and 35
had |log2 .0 with none of these genes shared with the EW AFB/CNTL comparison (Table S4).
Ten of th 35 genes showed significantly higher expression in th AFB1-treated group and 25 were
comparatively down-regulated. Greatest increase in expression was seen for LOC100539136 (growth
regulating estrogen receptor binding 1, GREB1), LOC104915640 (uncharacterized protein KIAA1755
homolog), LOC104911153 (uncharacterized ncRNA) and A1CF (APOBEC1 complementation factor)
with log2FC > 3.0 (Table S2). Greatest down-regulation in AFB1-treated compared to control-fed birds
was seen for LOC104912410 (uncharacterized ncRNA), TMSB4X (thymosin beta 4), LOC104910496
(amphiphysin-like, AMPH-like), and LOC104915519 (myelin-oligodendrocyte glycoprotein-l ke).
Gene ontology (GO) enrichment analysis of the 2253 significant DE gen s (Table S5) found
enrichment for genes associated with core processes of gene expression with highest enrichment
for the biological process categories of ribosomal small subunit assembly (GO:0000028, 9.54×
enrichment, p = 0.0135), proteasomal ubiquitin-independent protein catabolic process (GO:0010499,
7.35× enrichment, p = 0.027), and cytoplasmic translation (GO:0002181, 6.82× enrichment, p = 2.0× 10–7).
Highest enrichment in GO cellular component category was proteasome core complex, alpha-subunit
complex (GO:0019773, 11.7× enrichment, p = 0.356), cytosolic small ribosomal subunit (GO:0022627,
10.3× enrichment, p = 1.35× 10–12) and cyto olic l rge ribosomal subunit (GO:0022625, 9.35× e richment,
p = 7.21 × 10–16). Pathway analy is of th DEGs in ingenuity pathway a alysis (IPA) found the highest
z-score (5.37, (−log(p) = 41.2) for Eukaryotic Initiation Factor 2 (eIF2) signaling. Studies in mammalian
cells have shown that NF-κB activation and pro-inflammatory cytokine expression are dependent on
the eIF2 signaling pathway [29]. Translational regulation especially of pro-inflammatory cytokines is a
key innate immune response [29]. Pathway analysis also indicated activation of eIF2 signaling. eIF2 is
an essential factor for protein synthesis and a critical point in stress-induced translation.
2.2.2. Wild vs. Domesticated Turkey Control Groups
Transcriptome comparison between the control groups (EW versus DT) found 344 DEGs (false
discover rate (FDR) p < 0.05, Table 1) with log2FC ranging from −6.38 to 6.60 (Table S3). A total of 106
of these DEGs had |log2FC| > 2.0 (Figure 2, Table S6) and the majority (95) showed higher expression in
the EW group. Of the 106 genes, 63 were shared in common in the comparison with AFB1-treated
birds (Figure 2). Analysis of the 106 DEGs in the Database for Annotation, Visualization and Integrated
Discovery (DAVID) [30] found enrichment (E score = 1.96) for a group of membrane-associated genes
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AQP8 (aquaporin 8), CLRN3 (clarin 3), DIO2 (deiodinase, iodothyronine type II), FER1L6 (fer-1 like
family member 6), LOC100548708 (epithelial chloride channel protein-like), TMEM27 (transmembrane
protein 27) and solute carrier family genes (SLC1A1, SLC5A1, SLC5A8, SLC7A14, SLC7A9, SLC22A4 and
LOC100543156 [solute carrier family 22 member 13-like]). Cluster analysis identified two significant
annotation clusters including transporter activity (GO:0005215, p = 0.00074), and integral component of
membrane (GO:0016021, p = 0.0082). In addition, pathway analysis in IPA identified higher expression
of enzymes important in hormone metabolism and degradation such as sulfotransferases (6B1-like,
LOC104912373; 1C1-like, LOC100545251) and glucuronosyltransferase (UDP-glucuronosyltransferase
1-1-like, LOC100547885).
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Figure 2. Distribution of DEGs in turkey spleens. For each comparison between turkey types (wild and
domesticated), the number of shared or unique DEGs (FDR p < 0.05 and |log2FC| > 2.0) are indicated.
Direction of expression change (↑ or ↓) is given for each group and circle size is proportional to the
number of DEGs.
Of the 43 DEGs unique to the control group comparison, greatest up-regulation in the EW birds
was seen for BRINP3 (bone morphogenetic protein/retinoic acid inducible neural-specific 3, log2FC =
6.6) and LOC104915513 (histone deacetylase 7-like, log2FC = 6.2). In mammals, BRINP3 is primarily
expressed in the brain, and has been shown to be targeted to mitochondria and to inhibit neuronal
cell proliferation [31]. Histone deacetylase 7 is important in FOXP3 transcriptional regulation, cell
cycle progression and development [32]. Up-regulation of transcriptional regulators such as histone
deacetylase 7 (LOC104915513) potentially influences downstream transcriptional regulators such as
FOXP3, important in the development and inhibitory function of regulatory T-cells [33]. Greatest
down-regulation in the EW group was seen for 14-3-3 protein gamma-B (LOC104917314 [YWHAG],
log2FC = –6.4). This gene is part of a family of adapter proteins associated with the regulation of
several signaling pathways, apoptosis, cell cycle, and stress response [34,35].
2.2.3. Wild vs. Domesticated Turkey AFB1-treated
Compared to the control groups, a greater number of genes showed significant expression
differences between the EW and DT birds following AFB1 treatment. A total of 435 DEGs (FDR p < 0.05)
were observed with 216 having |log2FC| > 2.0 (Table 1). Expression of these 216 DEGs was directionally
biased, with 199 showing greater expression in EW birds and only 17 with higher expression in the DT
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group (Figure 2, Table S7). As discussed above, 63 DEGs were shared with the control comparison.
Among the unique DE genes highest up, regulation was observed for LOC104915725 (mitochondrial
ribosome-associated GTPase 1-like), AVPR1A (arginine vasopressin receptor 1A), SLCO4C1 (solute
carrier organic anion transporter family, member 4C1), and LOC100541395 (thyroid hormone-inducible
hepatic protein-like), each with log2FC > 5.0 (Table S7). Largest down regulation was observed
for LOC104915640 (uncharacterized protein KIAA1755 homolog), LOC104917003 (zonadhesin-like),
LOC104916581 (7-dehydrocholesterol reductase-like), and LOC104917133 (uncharacterized ncRNA),
all with log2FC < –4.0. Only one of the unique down-regulated genes (OPTC, opticin) was also DE
in the control group comparison. Interestingly, expression of the primary (CYP1A5) and secondary
(CYP3A37) hepatic AFB1-activating P450s was significantly higher in the DT birds. Two of the
shared genes that showed the highest expression differences were the INF-inducible genes MX1 (MX
dynamin-like GTPase) and RSAD2 (radical S-adenosyl methionine domain containing 2). Both of these
genes are believed to function in antiviral immune response. Further examination of these genes by
quantitative real time PCR (qRT-PCR) supported elevated expression in EW birds in both control and
AFB1-treatment groups. We also examined other domesticated (Broad Breasted White, BB) and wild
birds (Rio Grande Wild, RGW, M. g. intermedia) to further contrast the genetic types. Both of these
groups of birds (BB and RGW) showed similar expression patterns as the DT and EW comparison with
higher relative expression observed in the RGW birds compared to BB (Figure 3). Interestingly, wild
birds of both subspecies (EW and RGW) generally displayed higher levels of inter-individual variation
in the genes assayed.
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Figure 3. Effect of AFB1 on relative gene expression (log2) of selected genes in the spleens of turkeys as
measured by quantitative real time PCR (qRT-PCR). For each gene, the fold change (∆∆Ct) between
AFB1-treated and control birds is given. Bars denote 1 SE of the mean. DT = domesticated, EW =
Eastern wild, BB = Broad Breasted White domesticated, and RGW = Rio Grande ild. * significant
comparisons (p < 0.05).
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Gene pathway analysis of the DEGs identified in the EW vs. DT comparison revealed
highest significance for the canonical pathways representing FXR/RXR and LXR/RXR activation,
coagulation system, acute phase response signaling, prothrombin activation (extrinsic and intrinsic),
and atherosclerosis signaling (Figure 4). These pathways are necessarily related as 27 of the DE
genes in these pathways co-occur in at least one other pathway, and some genes like SERPINA1
(LOC100542070, alpha-1-antitripsin) and FGA (fibrinogen alpha chain), occur in six and five of the
pathways, respectively. Within these pathways, affected genes were primarily up regulated in EW
compared to DT as would be expected given the overall abundance of up-regulated genes in this
comparison (92%). Expression differences are particularly evident in the IPA acute phase response
signaling pathway with significantly higher expression observed in EW birds for several genes
(Figure S3). Given the extra-hepatic expression of these genes, 10 (AGT, AHSG, ALB, AMBP, FGA,
FGB, HPX, SAA-like [LOC104911020], SERPIND1, and TTR) were chosen for further examination and
confirmation by qRT-PCR. Elevated expression in each of the 10 genes in EW birds was supported
compared to DT birds (Figure 3). All showed greater expression in EW birds treated with AFB1
compared to controls and compared to AFB1-treated DT birds indicating up-regulation in response to
AFB1. Expression of seven genes was reduced by AFB1 treatment in DT birds suggesting the opposite
effect. For other domesticated (Broad Breasted White, BB) and wild birds (Rio Grande Wild, RGW),
gene expression as measured by qRT-PCR supported the findings seen in qRT of the EW and DT birds.
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3. Discussion
The combination of high toxicity and ubiquitous presence in feed, makes AFB1 a serious
concern for the poultry industry. Consumption of AFB1 has widespread physiological effects that
adversely affect poultry production. Exposed birds display general poor performance, decreased
growth nd reproductive depr ssion [3,36]. Consistent wi h immunot xicity, AFB1 als impairs
cell-mediated, hu oral, and phagocytic functions [2,13–15]. In addition, AFB1 exposure results in
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compromised immune response, making birds more susceptible to infectious diseases [15]. Importantly,
immunotoxic affects and blood-clotting abnormalities may occur at AFB1 doses lower than required to
elicit reduced performance [36,37]. The present study quantifies gene expression within the turkey
spleen transcriptome and identifies key expression differences between genetically susceptible and
resistant birds.
The effect of AFB1 on the spleen is the combined result of the systemic toxin and damage signaling
from the liver. Exposure to AFB1 in poultry is known to deplete splenic lymphocytes and generate
circulating lymphocytopenia [3,38,39]. Pathomorphological studies have shown significant reduction
in the density of lymphoid cells through lymphocytic degeneration [40–42]. Pathological changes in
the spleen are thought to result from increased oxidative stress, decreased glutathione (GSH) levels and
increased apoptosis [17,43]. Studies suggest that effects on the spleen are dependent on the effective
exposure and genetic susceptibility of the birds. For example, Zhu et al. [43] reported significantly
lower relative spleen weights in broiler chickens fed AFB1-contaminated diets (0.8 mg AFB1/kg feed),
whereas Peng et al. [44] reported a significant increase (82–134 µg AFB1/kg). Grozeva et al. [42] found
significantly lower relative spleen weights in AFB1-fed commercial strain turkey poults (0.2 and 0.4 mg
AFB1/kg), whereas Quist et al. [25] reported slightly lower (non-significant) spleen weight in AFB1-fed
wild turkeys (100–400 µg AFB1/kg). To facilitate rapid collection of tissues, splenic weights were not
recorded in the present study, however, the effects of AFB1 on body weight and liver mass in these
same birds are summarized in a companion study of hepatic gene expression [12].
The spleen is unique in its combination of discrete functions enabling innate and adaptive
immune responses [45]. Up-regulation of a diverse set of coagulation factors, cell cycle regulators, and
Nrf2-mediated response genes was previously observed in turkey embryos with AFB1 exposure [46].
Our comparison of AFB1-treated EW vs. DT birds identified significant association of DEGs with the
canonical pathways for coagulation system and acute phase response signaling. Coagulation activation
produces proteases that can interact with cell receptors and induce signaling pathways to up-regulate
pro-inflammatory mediators [47] thereby increasing inflammation. Gene expression changes in the
coagulation system are consistent with altered coagulation times observed in poultry following AFB1
exposure [25,37,48].
Acute-phase proteins (APPs) are proteins that respond to infection or tissue damage (inflammation)
either by a significant increase (positive) or decrease (negative) in plasma concentration [49]. As a
component of the innate immune system, APPs have antimicrobial, coagulatory, negative feedback
functions [50]. APPs and their role in the acute phase response are widely reported in both humans
and other mammals (reviewed in [51]). Although primarily synthesized by hepatocytes in the liver,
expression of APPs is common in other tissues, even under normal conditions [52]. In this regard, focal
expression of APPs in the turkey spleen in response to AFB1 is not unexpected. In the chicken, five
APPs, including alpha 1-acid glycoprotein (AGP), serum amyloid A (SAA), PIT54 (turpentine-induced
18-B), C-reactive protein (CRP), and ovotrasferrin (OVT), are expressed in extrahepatic tissues of
healthy birds [53]. In particular, SAA was highly expressed in the secondary lymphatic tissues of
the chicken cecal tonsil and spleen. As seen in the RNAseq and qRT analyses, several APPs were
expressed at significantly higher levels in wild turkey spleens compared to those of domesticated birds
in response to AFB1 treatment. Many of these same genes were also similarly expressed at higher
levels in the livers of these same birds [12].
Our study of the effects of AFB1 on splenic gene expression in domestic turkeys [23] found that
acute AFB1 exposure suppressed innate immune transcripts, especially from antimicrobial genes.
Also evident was up-regulation of transcripts indicative of either increased cytotoxic potential or
activation-induced cell death in the spleen during aflatoxicosis. This earlier study was conducted
prior to the availability of the turkey whole-genome sequence and relied on de novo assembly of
RNAseq reads to identify gene transcripts. Comparison of AFB1-treated DT birds with controls
found 391 transcripts to be differentially expressed. Although the majority (88.4%) of the significant
differentially expressed transcripts unique to the AFB1-treatment group were up-regulated, transcripts
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from several innate immune genes, such as lysozyme G (LYG), leukocyte cell-derived chemotaxin 2
(LECT2), beta-defensin 1 (THP1), and beta-defensin 2 (THP2) were significantly down-regulated. Given
the limitations in equating gene IDs in the current genome annotation to transcripts in the Monson
et al. study [23], comparison of DEGs in the present study identified only 22 (representing 20 genes)
common to both studies. The majority of these had small relative expression changes (|log2FC|< 2).
For example, in the present study expression of LECT2 and THP2 were slightly lower in EW birds
treated with AFB1 compared to DT birds but did not show a significant response to AFB1 compared to
EW controls. However, other genes like UMP-CMP kinase 2 mitochondrial (CMPK2) were uniquely
upregulated in EW. This gene may function in terminal differentiation of monocytic cells and as an
enzyme in the nucleotide synthesis salvage pathway [54].
Domesticated turkeys, like humans, lack hepatic alpha-class GSTAs with high activity toward
AFB1 [55]. In contrast, livers of wild and heritage turkeys possess GST-mediated AFBO detoxification
activity [10] and are relatively resistant to aflatoxicosis [25]; suggesting a loss-of-function concomitant
with genetic selection for the modern commercial bird. The effects of AFB1 in domesticated turkeys and
the lessened effect in wild birds is multifactorial. Although the hepatic transcriptome is dysregulated
by AFB1 in all turkeys, significant differences between wild and domestic birds are apparent in the
expression of phase I and phase II drug metabolism genes, and genes involved in cellular regulation,
modulation of apoptosis and inflammatory responses [12,46]. Further evidence for the role of genetic
background in response to AFB1 is seen in the differential activation of the inflammatory response in
the spleens of wild birds compared to their domesticated counterparts consistent with our studies of
the cecal tonsil (intestine) of the same birds [26]. Greater inter-individual variation in gene expression
as measured by qRT-PCR was also observed in the wild birds. Combined, these studies demonstrate
that in addition to the presence of functional hepatic GST-mediated AFB1 detoxifying capability, wild
turkeys possess a capacity to more effectively respond to AFB1 exposure.
4. Materials and Methods
This study used turkey strains (Eastern wild (EW, resistant) and domesticated (DT, susceptible))
previously demonstrated to vary in AFB1-detoxifying GST activity. Animal husbandry and the AFB1
treatment protocol were as described in Reed et al. [12]. All procedures were approved by Utah State
University’s Animal Use and Care Committee (Approval #2670, 26 September 2016).
4.1. RNA Isolation, Sequencing and RNAseq Data Analyses
Total RNA isolation, quantification and preparation for sequencing was as previously
described [12]. RNA Integrity Numbers (RIN) averaged 6.2 and libraries (four replicate samples
per treatment group) were prepared and sequenced (101 bp paired-end reads) at the University of
Minnesota Genomics Center (UMGC) on the HiSeq 2000 using v2 chemistry (Illumina, Inc.). Raw data
were deposited in the NCBI’s Gene Expression Omnibus (GEO) repository as SRA BioProject 346253.
Analysis of RNAseq data followed the protocols outlined in Reed et al. [12].
4.2. Quantitative Real-Time PCR
Quantitative real-time PCR (qRT-PCR) of AFB1-treated and control animals was used to test
expression of select genes. Selected for analysis were the wild and domesticated turkey used for
RNAseq analysis, plus other samples of genetically distinct domesticated (Broad Breasted White, BB)
and wild birds (Rio Grande subspecies, RGW, M. g. intermedia) from a parallel challenge experiment.
Of the six samples from the DT and EW groups used for qRT-PCR, four were in common with the
RNAseq study. Synthesis of cDNA was performed on DNase-treated mRNA with Invitrogen Super
Script IV First-strand synthesis kit (Invitrogen, Carlsbad, CA, USA). PCR primers were designed with
Primer3 software [56]. Primer sets were designed using the turkey genome (UMD5.0) to span at
least one intron (exon/exon junction) to limit artifact DNA amplification. Normalizing genes were
tested for uniformity and the most stable reference (ribosomal protein L4, RPL4) was determined
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with RefFinder [57]. Stability values for RPL4 were 0.209 and 0.266 as calculated by Normfinder and
Genorm, respectively. Quantitative analysis of gene-specific amplicons was done using the Quanta
PerfecTa Sybr Fastmix (Quanta, Biosciences, Inc, Gaithersburg, MD, USA) run on a CFX96 touch
real-time detection system (BioRad, Hercules, CA, USA). Each target gene reaction was run in triplicate,
with duplicate normalization, no template and gDNA control reactions. Expression was normalized to
RPL4 and interpreted by Double Delta Ct Analysis (∆∆Ct, [58]) using the standard workflow within
the CFX Maestro software package (1.0, Bio-Rad, Hercules, CA, USA).
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/11/5/242/s1,
Figure S1: Distribution of expressed genes in turkey spleen by treatment group; Figure S2: Summary of principal
component analysis (PCA) of by-total normalized RNAseq read counts; Figure S3: Effect of AFB1 on expression
of turkey genes in the IPA canonical pathway “acute phase signaling”; Table S1: Summary of RNAseq data for
turkey spleen transcriptomes; Table S2: Mean quality-trimmed RNAseq read counts for turkey spleen from two
turkey types (wild and domesticated); Table S3: Summary of pair-wise differential gene expression analysis of
spleen transcriptomes; Table S4: Genes showing significant differential expression in AFB1-treated versus control
groups in domesticated turkey; Table S5: Summary of overrepresentation test (PANTHER (GO Consortium
release 20150430, [59]) of the 242 differentially expressed genes (|log2FC| > 1.0) in the AFB1-treated DT birds as
compared to controls; Table S6: Genes showing significant differential expression (FDR p < 0.05 and |log2FC| > 2.0)
in EW versus DT control groups; Table S7: Genes showing significant differential expression (FDR p < 0.05 and
|log2FC| > 2.0) in comparison of EW versus DT AFB1 groups.
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